Loading...
XSHE
002172
Market cap461mUSD
Dec 05, Last price  
4.26CNY
1D
0.47%
1Q
0.95%
Jan 2017
-58.36%
IPO
-65.23%
Name

Jiangsu Aoyang Health Industry Co Ltd

Chart & Performance

D1W1MN
XSHE:002172 chart
P/E
80.42
P/S
1.62
EPS
0.05
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-7.59%
Revenues
2.01b
-7.54%
985,574,1111,320,958,8122,087,321,4321,634,642,4282,340,465,8443,805,268,6453,823,992,5583,552,361,5403,277,439,6782,931,164,3883,808,778,5934,875,817,8335,366,490,3214,710,672,8762,982,034,9523,083,401,1793,028,918,8112,021,311,3172,173,767,5662,009,775,237
Net income
41m
-18.36%
58,002,34186,215,374216,937,5440161,105,804100,458,230035,652,82020,912,5310135,862,289259,242,227154,658,56610,359,785000049,681,62340,561,915
CFO
439k
-99.19%
240,863,00356,235,5520320,511,918184,258,82700544,264,366238,730,309494,924,498334,683,988555,087,08599,606,13200125,329,1790054,303,048438,651
Dividend
Apr 17, 20080.15 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jiangsu Aoyang Health Industry Co.ltd. produces and sells chemical fibers in China and internationally. It offers various functional fibers, as well as conventional viscose fibers. The company also operates hospitals, rehabilitation centers, and pharmaceutical retail chains. In addition, it offers health management and pharmaceutical logistics, as well as distributes pharmaceutical products. The company was formerly known as Jiangsu Aoyang Technology Corporation Limited. and changed its name to Jiangsu Aoyang Health Industry Co.ltd. in September 2018. Jiangsu Aoyang Health Industry Co.ltd. was founded in 2001 and is based in Zhangjiagang, China.
IPO date
Sep 21, 2007
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT